# Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)

> **NCT01254799** · PHASE3 · COMPLETED · sponsor: **Omar Mamdouh Shaaban** · enrollment: 68 (actual)

## Conditions studied

- Uterine Hemorrhage

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01254799
- **Lead sponsor:** Omar Mamdouh Shaaban
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-09
- **Final completion:** 2011-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2011-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01254799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01254799, "Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01254799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*